Liver precise expression composition, vaccine composition and their applications

TW202637197APending Publication Date: 2026-09-16RINUAGENE BIOTECHNOLOGY CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114147853
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-12-05
Filing Date
2025-12-05
Publication Date
2026-09-16

Smart Images

  • Figure TWG2TA001076647_001
    Figure TWG2TA001076647_001
  • Figure TWG2TA001076647_002
    Figure TWG2TA001076647_002
  • Figure TWG2TA001076647_003
    Figure TWG2TA001076647_003
Patent Text Reader

Abstract

A lipid nanoparticle composition that is easily enriched in the liver; the liver precise expression composition can be used to prepare lipid nanoparticles or vaccine composition, and can be efficiently delivered to the liver, its tissues, and cells, significantly reducing the expression of target genes in non liver organs and avoiding side effects caused by unexpected expression, such as inflammatory reactions or other off target effects.
Need to check novelty before this filing date? Find Prior Art